ArticleMolecular and clinical oncology2018
Phase I study of third-line palliative chemotherapy with low dose paclitaxel for pancreatic cancer.
Hidehiro Tajima et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it